Pharmaceutical giant Novo Nordisk's headquarters in Denmark caught fire, the second such incident in less than a week.
The Zhitong Finance App learned that a fire broke out at the headquarters of pharmaceutical giant Novo Nordisk (NVO.US) in Denmark. This is the second such incident in less than a week.
A company spokesperson said in an email that the site affected by the fire was not being used for production. Earlier on Wednesday, the fire broke out outside a Novo Nord building in Bagsvaerd and then spread to a nearby office building, she said. The spokesperson said at noon on Wednesday local time that the fire “is expected to last several hours” to be extinguished.
Before the US stock market on Wednesday, Novo Nordisk's stock price fell nearly 2% as of press release. The stock has accumulated a 31% increase so far this year.
According to information, with the best-selling weight loss and diabetes drugs Wegovy and Ozempic, Novo Nordisk has become the company with the highest market capitalization in Europe, and the Danish pharmaceutical company is currently investing heavily to expand in Denmark and overseas. Prior to this week's fire, a fire also broke out on the roof of a building under construction at Novo Nord's manufacturing center in Kalundborg on May 16. The company is spending more than $8 billion to increase production at the Kalundborg manufacturing center.
According to the Copenhagen Fire Service, around 100 firefighters battled the “blaze” at the scene on Wednesday. A Novo Nordisk spokesperson said the smoke from Wednesday's fire was not toxic, and no one was injured.
Local police said in a post on X that the fire affected visibility of the Hillerod Expressway.